Cargando…
Prognostic value of (18)F-FDG PET/CT in patients with advanced or metastatic non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis
PURPOSE: This study aimed to investigate the value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in predicting early immunotherapy response of immune checkpoint inhibitors (ICIs) in patients with advanced or metastatic non-small-cell lung cancer (NSC...
Autores principales: | Ling, Tao, Zhang, Lianghui, Peng, Rui, Yue, Chao, Huang, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713836/ https://www.ncbi.nlm.nih.gov/pubmed/36466905 http://dx.doi.org/10.3389/fimmu.2022.1014063 |
Ejemplares similares
-
Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017) -
The Prognostic Value of (18)F-FDG PET/CT and KRAS Mutation in Colorectal Cancers
por: Arslan, Esra, et al.
Publicado: (2020) -
Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022) -
The Prognostic and Diagnostic Value of [(18)F]FDG PET/CT in Untreated Laryngeal Carcinoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2023) -
Value of (18)F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary
por: Li, Yuekai, et al.
Publicado: (2020)